by Janneke de Haan | Dec 14, 2021 | Interview, News
Meet the partner: Lygature Within Immune-Image, Lygature co-leads the data management work package, WP2, taking overall responsibility for the timely delivery of the deliverables and milestones in the various subtasks and the creation and execution of the data...
by Janneke de Haan | Dec 13, 2021 | Interview, News
Patient interview: Seamus Cotter We interviewed Seamus Cotter from Ireland about his experiences with immunotherapy. Seamus has stage IV NSCLC lung cancer, was diagnosed in June 2016, and is now in remission. We asked him how he found out about immunotherapy, which...
by Janneke de Haan | Nov 15, 2021 | Interview, News
“PET-imaging can be really valuable for clinical practice for several rheumatic diseases in the near future” Conny van der Laken is a rheumatologist and a principal investigator of advanced imaging studies in rheumatology at the University of Amsterdam. Within the...
by Daisy van Schaijik | Apr 30, 2021 | Interview, News
''Imaging a particular immune cell subpopulation, that is the holy grail'' Professor Nick Devoogdt is, together with Wouter Driessen of Roche, leader of work package 3 of the Immune-Image project. In this work package their team develops new immunotracers for cancer...
by Daisy van Schaijik | Apr 30, 2021 | Interview, News
''Within Immune-Image we actually want to deliver new immunotracers to the patients'' Natascha Stergiou is a researcher (postdoc) for the Immune-Image project in work package 3 and is developing a universal and inert labeling protocol for immune cells which will be...
by Daisy van Schaijik | Apr 30, 2021 | Interview, News
Meet our partner: Kevin Maresca from Pfizer Kevin Maresca works in Early Clinical Development within Pfizer’s Worldwide Research, Development and Medical (WRDM) organization. He is head of PET/Molecular Imaging within the Digital Medicine and Translational Imaging...
Recent Comments